Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: A pragmatic, randomized, multicenter, non-inferiority clinical trial
The FDA declared more than a year ago that there was no longer a shortage and, this month, announced it had sent letters to 30 telehealth companies that warned them to stop illegally marketing compounded GLP-1s
1999;33(4):p
With a late-stage clinical pipeline running smoothly and strong growth in 2023 of its key market drivers, Amgen is eyeing annual revenue of $32.4 billion on the low end and up to $33.8 billion for 2024
GLP-1 peptides are incretin-mimetic peptide drugs that activate the glucagon-like peptide-1 receptor (GLP-1R), a key metabolic receptor involved in glucose-dependent insulin secretion, suppression of glucagon release, delayed gastric emptying, and appetite regulation
Track Your Injections : Keep a record of each injection